Status:
COMPLETED
EFFECTS OF PYRROLOQUINOLINE QUINONE (PQQ) SUPPLEMENTATION ON NON-ENDURANCE TRAINED ATHLETES
Lead Sponsor:
University of Padova
Conditions:
Mitochondrial Biogenesis
Inflammation
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
The aim of this study was to investigate the effects of six weeks of PQQ supplementation in non-endurance-trained individuals on: 1. physiological and metabolic response during a FATmax-VO₂peak exerc...
Eligibility Criteria
Inclusion
- 1\) Age: Participants aged between 18 and 40 years.
- 2\) Body mass index (BMI): BMI within the range of 18-30 kg/m².
- 4\) Physical activity: Regular engagement in non-endurance physical activities (3-4 times a week), with no participation in structured endurance training programs.
Exclusion
- 1\) chronic disease;
- 2\) acute illness; and
- 3\) use of dietary supplements, pharmacological agents, or adherence to a hypocaloric diet.
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2025
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT07148726
Start Date
September 1 2024
End Date
August 15 2025
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nutrition and Exercise Lab, DSB, University of Padova
Padua, Italy, Italy, 35131